Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia
Author:
Funder
Walther Cancer Foundation
National Institutes of Health
National Cancer Institute
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference27 articles.
1. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia;A Hochhaus;Leukemia,2009
2. Ther Adv Hematol;J Ai,2014
3. Management of chronic myeloid leukaemia in clinical practice in France: results of the French subset of patients from the UNIC study;M Michallet;Curr Med Res Opin,2010
4. Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: a randomised trial of the Dutch-Belgian Cooperative Trial for Haemato-Oncology (HOVON);N Thielen;Eur J Cancer,2013
5. Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance;D Bixby;ASH Education Program Book,2009
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Suppression of endoplasmic reticulum stress by 4-PBA enhanced atherosclerotic plaque stability via up-regulating CLOCK expression;Pathology - Research and Practice;2024-01
2. Effect of combined administration of Acyl-CoA: Cholesterol acyltransferase 1 inhibitor and glucagon-like peptide 1 receptor agonist on a rodent model of diet-induced obesity;Biochemical and Biophysical Research Communications;2023-12
3. Stimulated Raman scattering microscopy in the analysis of cancer cells – A review and own research;TrAC Trends in Analytical Chemistry;2023-12
4. Dual-Activity Fluoroquinolone-Transportan 10 Conjugates Offer Alternative Leukemia Therapy during Hematopoietic Cell Transplantation;Molecular Pharmacology;2023-11-17
5. Reversible translocation of acyl-CoA:cholesterol acyltransferase (ACAT) between the endoplasmic reticulum and vesicular structures;Frontiers in Molecular Biosciences;2023-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3